These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26823568)

  • 1. Radiation Dosimetry of Whole-Body Dual-Tracer 18F-FDG and 11C-Acetate PET/CT for Hepatocellular Carcinoma.
    Liu D; Khong PL; Gao Y; Mahmood U; Quinn B; St Germain J; Xu XG; Dauer LT
    J Nucl Med; 2016 Jun; 57(6):907-12. PubMed ID: 26823568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation dosimetry of 18F-FDG PET/CT: incorporating exam-specific parameters in dose estimates.
    Quinn B; Dauer Z; Pandit-Taskar N; Schoder H; Dauer LT
    BMC Med Imaging; 2016 Jun; 16(1):41. PubMed ID: 27317478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
    Ho CL; Chen S; Yeung DW; Cheng TK
    J Nucl Med; 2007 Jun; 48(6):902-9. PubMed ID: 17504862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 11C-acetate and 18F-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization.
    Park S; Kim TS; Kang SH; Kim HB; Park JW; Kim SK
    Medicine (Baltimore); 2018 Sep; 97(37):e12311. PubMed ID: 30212970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioembolization with
    Ho CL; Chen S; Cheung SK; Leung YL; Cheng KC; Wong KN; Wong YH; Leung TWT
    Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2110-2121. PubMed ID: 29948107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in diagnostic impact of dual-tracer PET/computed tomography according to the extrahepatic metastatic site in patients with hepatocellular carcinoma.
    Yoo SW; Kim DY; Pyo A; Jeon S; Kim J; Kang SR; Cho SG; Lee C; Kim GJ; Song HC; Bom HS; Min JJ; Kwon SY
    Nucl Med Commun; 2021 Jun; 42(6):685-693. PubMed ID: 33625183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma.
    Chalaye J; Costentin CE; Luciani A; Amaddeo G; Ganne-Carrié N; Baranes L; Allaire M; Calderaro J; Azoulay D; Nahon P; Seror O; Mallat A; Soussan M; Duvoux C; Itti E; Nault JC
    J Hepatol; 2018 Aug; 69(2):336-344. PubMed ID: 29518452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective evaluation of radiation dose associated with low dose FDG protocols in whole-body PET/CT.
    Willowson KP; Bailey EA; Bailey DL
    Australas Phys Eng Sci Med; 2012 Mar; 35(1):49-53. PubMed ID: 22160927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-specific radiation dose for Chinese pediatric patients undergoing whole-body PET/CT examinations.
    Jia H; Xue M; Li X; Zhuang M; Xie T
    Phys Med Biol; 2024 Jun; 69(12):. PubMed ID: 38776955
    [No Abstract]   [Full Text] [Related]  

  • 10. Can positron emission tomography with the dual tracers [11 C]acetate and [18 F]fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma?
    Cheung TT; Chan SC; Ho CL; Chok KS; Chan AC; Sharr WW; Ng KK; Poon RT; Lo CM; Fan ST
    Liver Transpl; 2011 Oct; 17(10):1218-25. PubMed ID: 21688383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of patient dose in (18)F-FDG and (18)F-FDOPA PET/CT examinations.
    Kaushik A; Jaimini A; Tripathi M; D'Souza M; Sharma R; Mishra AK; Mondal A; Dwarakanath BS
    J Cancer Res Ther; 2013; 9(3):477-83. PubMed ID: 24125986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-adapted organ absorbed dose and effective dose estimates in pediatric 18F-FDG positron emission tomography/computed tomography studies.
    Quinn BM; Gao Y; Mahmood U; Pandit-Taskar N; Behr G; Zanzonico P; Dauer LT
    BMC Med Imaging; 2020 Jan; 20(1):9. PubMed ID: 31996149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation Dosimetry of a Novel Adenosine A
    Zhou X; Elsinga PH; Khanapur S; Dierckx RA; de Vries EF; de Jong JR
    Mol Imaging Biol; 2017 Apr; 19(2):289-297. PubMed ID: 27539309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 11C-acetate and 18F-FDG PET/CT for clinical staging and selection of patients with hepatocellular carcinoma for liver transplantation on the basis of Milan criteria: surgeon's perspective.
    Cheung TT; Ho CL; Lo CM; Chen S; Chan SC; Chok KS; Fung JY; Yan Chan AC; Sharr W; Yau T; Poon RT; Fan ST
    J Nucl Med; 2013 Feb; 54(2):192-200. PubMed ID: 23321459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. F-18 FDG in conjunction with 11C-choline PET/CT in the diagnosis of hepatocellular carcinoma.
    Wu HB; Wang QS; Li BY; Li HS; Zhou WL; Wang QY
    Clin Nucl Med; 2011 Dec; 36(12):1092-7. PubMed ID: 22064078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new upper limit for effective dose in patient administered with 18F-FDG for PET/CT whole-body imaging with diagnostic CT parameters.
    Velo P; Ismail MI; Mohandas KK; Kasilingam L
    J Med Imaging Radiat Sci; 2023 Mar; 54(1):43-50. PubMed ID: 36402716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-Tracer PET/CT Using 18F-FDG and 11C-Acetate in Gastric Adenocarcinoma With Liver Metastasis.
    Vardhanabhuti V; Lo AW; Lee EY; Law SY
    Clin Nucl Med; 2016 Nov; 41(11):864-865. PubMed ID: 27648704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel weight-based dose threshold for 18F-NaF PET-CT imaging using advanced PET-CT systems: a potential tool for reducing radiation burden.
    Marafi F; Esmail A; Rasheed R; Alkandari F; Usmani S
    Nucl Med Commun; 2017 Sep; 38(9):764-770. PubMed ID: 28723715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.
    Park JW; Kim JH; Kim SK; Kang KW; Park KW; Choi JI; Lee WJ; Kim CM; Nam BH
    J Nucl Med; 2008 Dec; 49(12):1912-21. PubMed ID: 18997056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET-Based Human Dosimetry of
    Boss M; Buitinga M; Jansen TJP; Brom M; Visser EP; Gotthardt M
    J Nucl Med; 2020 Jan; 61(1):112-116. PubMed ID: 31519801
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.